Dr. Thilo Enderle appointed as new Chief Executive Officer of Hit Discovery Constance GmbH
Jan 10, 2019
Milan (Italy)/Constance (Germany) – Axxam announces the appointment of Dr. Thilo Enderle as Chief Executive Officer of Hit Discovery Constance (HDC), a joint venture company held by Axxam, the Centre for Drug Design and Discovery (CD3) of KU Leuven (Leuven, Belgium) and Lead Discovery Center GmbH (Dortmund, Germany).
Thilo’s arrival will strengthen further the collaboration between Axxam and HDC in offering high quality discovery services, including high-throughput screening in a range of different modalities including fluorescence, luminescence, radiometric as well as high content screening.
Stefan Lohmer, Chairman and Chief Executive Officer of Axxam, said: “We are working with our colleagues at HDC as an integrated team and we are very pleased to welcome Thilo to the group and looking forward to leveraging his tremendous industrial HTS and lead discovery experience for the purpose of continuously delivering outstanding results to our partners and clients”.
For more information please open the Press Release from HDC